The global population health management solutions market is expected to grow at a CAGR of 12.6% from 2021 to reach USD 51.4 billion by 2027. The growth is primarily attributed to government initiatives, growing usage of big data analytics, emphasis on reducing healthcare costs, focus on personalized medicines and demand for value-based medicine. However, lack of data analysts, data breaches and interoperability pose significant challenge to the growth of population health management solutions market.
By Component: Software segment dominated the population health management market in 2021
Software segment accounted for the largest share of population health management solutions market. The largest share of this segment is mainly due to growing adoption of software solutions and thus providing cost-effectiveness, increasing operational abilities, improved data integration and better patient engagement
By Mode of delivery, On-premise accounted for the largest market share
Population health management solutions market is segmented into on-premise and cloud based by mode of delivery. On-premise accounted for largest market share in the population health management solutions market. The large share of this segment can be attributed to scope of customization, less risk of data breaches and reuse of existing servers.
By End User: Healthcare providers segment dominated the population health management solutions market
Based on the end user segregation, healthcare providers segment accounted to largest market share in 2020. The large share of this market segment can be explained by escalating demand of these solutions and implementations of laws for reducing healthcare expense by using these solutions.
By Region: APAC is the fastest growing regional market while North America maintains lead
In 2020, North America accounted for the largest share of population health management solutions market. The large share is mainly due to initiatives for reducing hospital costs, improving regulatory framework, increasing adoption of EHRs and focus on personalized medicines & reimbursements. APAC showed spike in growth due to implementation of new guidelines, government initiatives, prevalence of chronic diseases, rapidly growing healthcare infrastructure and rising medical tourism.
Competitive Scenario
- Cerner Corporation (US)
- Epic Systems Corporation (US)
- Koninklijke Philips (Netherlands)
- i2i Population Health (US)
- Health Catalyst (US)
- Optum (US)
- Enli Health Intelligence (US)
- eClinicalWorks (US)
- Orion Health (New Zealand)
- Allscripts Healthcare Solutions (US)
- IBM Corporation (US)
- HealthEC LLC (US)
- Medecision (US)
- Arcadia (US)
- athenahealth (US)
- Cotiviti (US)
- NextGen Healthcare Inc. (US)
- Conifer Health Solutions (US)
- SPH Analytics (US)
- Lightbeam Health Solutions (US)
- Innovaccer (US)
- Citra Health Solutions (US)
- Evolent Health Inc. (US)
- Lumeris (US)
- Forward Health Group (US)
1. Introduction
2. Research Methodology
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. COVID-19 Impact of the Population Health Management Solutions Market
5. Industry Insights
5.1. Introduction
5.2. Industry Trends
6. Global Population Health Management Solutions Market, By Component, 2019-2027 (USD Million)
6.1. Introduction
6.2. Software
6.3. Services
7. Global Population Health Management Solutions Market, By Mode of Delivery, 2019-2027 (USD Million)
7.1. On-premise mode of delivery
7.2. Cloud-based mode of delivery
8. Global Population Health Management Solutions Market, By End User, 2019-2027 (USD Million)
8.1. Healthcare providers
8.2. Healthcare payers
8.3. Other end users
9. Global Population Health Management Solutions Market, By Geography, 2019-2027 (USD Million)
9.1. North America
9.1.1. US
9.1.2. Canada
9.2. Europe
9.2.1. Germany
9.2.2. UK
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia-Pacific
9.3.1. China
9.3.2. Japan
9.3.3. India
9.3.4. Rest of Asia-Pacific
9.4. Rest of the World
9.4.1. Latin America
9.4.2. Middle East & Africa
10. Competitive Landscape
10.1. Introduction
10.2. Market Share Analysis
10.3. Competitive Situation and Trends
10.3.1. Product Launches
10.3.2. Partnerships, Collaborations and Agreements
10.3.3. Acquisitions
10.3.4. Expansions
10.3.5. Other Developments
11. Company Profiles
11.1. Cerner Corporation (US)
11.2. Epic Systems Corporation (US)
11.3. Koninklijke Philips (Netherlands)
11.4. i2i Population Health (US)
11.5. Health Catalyst (US)
11.6. Optum (US)
11.7. Enli Health Intelligence (US)
11.8. eClinicalWorks (US)
11.9. Orion Health (New Zealand)
11.10. Allscripts Healthcare Solutions (US)
11.11. IBM Corporation (US)
11.12. HealthEC LLC (US)
11.13. Medecision (US)
11.14. Arcadia (US)
11.15. athenahealth (US)
11.16. Cotiviti (US)
11.17. NextGen Healthcare, Inc. (US)
11.18. Conifer Health Solutions (US)
11.19. SPH Analytics (US)
11.20. Lightbeam Health Solutions (US)
11.21. Innovaccer (US)
11.22. Citra Health Solutions (US)
11.23. Evolent Health, Inc. (US)
11.24. Lumeris (US)
11.25. Forward Health Group (US).
12. Appendix
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.